Madden Securities’s GSK GSK Stock Holding History

Madden Securities’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.8M	Sell	53,430 -3,750	-7%	-$198K	0.78%	35
2026 Q1	$3.16M	Sell	57,180 -250	-0.4%	-$13.5K	0.95%	30
2025 Q4	$2.82M	Sell	57,430 -300	-0.5%	-$14K	0.86%	34
2025 Q3	$2.49M	Sell	57,730 -39,175	-40%	-$1.53M	0.76%	35
2025 Q2	$3.72M	Sell	96,905 -9,925	-9%	-$379K	1.25%	26
2025 Q1	$4.14M	Buy	106,830 +19,400	+22%	+$710K	1.61%	16
2024 Q4	$2.96M	Buy	+87,430	New	+$3.15M	1.18%	22
2023 Q1	–	Sell	-2,080	Closed	-$73.1K	–	194
2022 Q4	$73.1K	Buy	+2,080	New	+$69.3K	0.04%	162

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Madden Securities's GSK Position: Q2 2026 in Review

Madden Securities reduced its GSK (GSK) stake by 6.6% in Q2 2026, selling an estimated $198K and leaving 53,430 shares worth $2.8M. The position accounts for 0.78% of the portfolio, ranked #35.

Madden Securities first reported a position in GSK in Q4 2022 and has held it in 8 quarters since. The position peaked at $4.14M in Q1 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Madden Securities held 53,430 shares of GSK worth $2.8M as of Q2 2026.
Madden Securities sold 3,750 GSK shares in Q2 2026, an estimated $198K.
GSK made up 0.78% of Madden Securities's portfolio in Q2 2026, its #35 holding.
Madden Securities first reported a position in GSK in Q4 2022 and has held it in 8 quarters since.
Madden Securities's GSK position peaked at $4.14M in Q1 2025.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Madden Securities's 13F filing for Q2 2026, filed 24 Jul 2026.